-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
February 11: The Week in Cancer NewsMillions miss cancer screenings, and commercial tobacco ban goes into effect for Navajo Nation after years of failed attempts.
by Marci A. Landsmann
-
February 4: The Week in Cancer NewsCAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
by Eric Fitzsimmons
-
January 21: The Week in Cancer NewsMetastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
by Kevin McLaughlin
-
January 14: The Week in Cancer NewsCancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.
by Eric Fitzsimmons
-
Cancer, On and Off StageErin Cronican, who has stage IV breast cancer, plays the lead role of a professor diagnosed with metastatic ovarian cancer in the New York City production of Wit.
by Pamela Rafalow Grossman
-
January 7: The Week in Cancer NewsThree out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
by Marci A. Landsmann
-
Acknowledging the Stress of CancerA patient advocate session at the San Antonio Breast Cancer Symposium offered practical tips for dealing with cancer.
by Marci A. Landsmann
-
Cracking the Code of Acute Myeloid LeukemiaTesting for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
by Kendall K. Morgan
-
December 17: The Week in Cancer NewsFDA approves drug to prevent graft versus host disease and decline in lung cancer deaths linked to screening.
by Kevin McLaughlin
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
